From Name:
From Email:
To Name:
To Email:

Optional Message:

CoC launches Special Study

from ACS-CRP

The Commission on Cancer (CoC) initiated a pilot study at 20 CoC-accredited facilities in the fall of 2017 as a component of the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) clinical trial (PIs: Drs. Shelley Hwang, Ann Partridge, Alastair Thompson). The study examines the risks and benefits of active surveillance compared with usual care for patients diagnosed with low risk ductal carcinoma in situ (DCIS), commonly known as stage 0 breast cancer. The pilot study concluded Jan. 1, 2018. Following data analysis, a CoC Special Study will be launched in spring 2018 to investigate outcomes from DCIS treatment retrospectively. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063